SkinHealth Systems Inc. (SKIN)

SkinHealth Systems Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	112.39	230.67	368.06	523.03	568.2	901.89
Cash & Short-Term Investments	112.39	230.67	368.06	523.03	568.2	901.89
Cash Growth	-48.30%	-37.33%	-29.63%	-7.95%	-37.00%	9407.55%
Accounts Receivable	18.47	21.74	27.64	54.7	76.49	46.82
Other Receivables	1.83	1.7	0.82	15.33	7.28	4.6
Receivables	20.3	23.44	28.46	70.03	83.77	51.42
Inventory	46.25	48.01	69.11	91.32	109.66	35.26
Prepaid Expenses	22.65	5.4	9.49	13.88	21.65	12.32
Restricted Cash	-	2	2	-	-	-
Total Current Assets	201.59	309.52	477.12	698.25	783.28	1,001
Property, Plant & Equipment	20.87	14.11	19.57	26.35	33.82	31.18
Goodwill	126.12	126.62	123.5	125.82	124.59	123.69
Other Intangible Assets	27.61	35.76	47.51	62.12	46.39	56.01
Long-Term Deferred Tax Assets	2.16	1.93	3.89	0.53	0.82	0.33
Other Long-Term Assets	10.7	11.87	14.09	16.04	14.19	6.71
Total Assets	389.06	499.8	685.68	929.11	1,003	1,219

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	15.09	15.63	21.94	44.77	28.47	29.05
Accrued Expenses	51.09	39.32	35.26	41.42	35.04	40.45
Short-Term Debt	-	-	-	-	1.82	2.15
Current Portion of Long-Term Debt	-	123.96	-	-	-	-
Current Portion of Leases	3.59	5.13	5.15	4.6	4.96	3.71
Current Income Taxes Payable	0.07	1.23	3.43	2.76	1.43	0.29
Current Unearned Revenue	-	1.01	2.38	0.45	-	-
Other Current Liabilities	-	-	-	21.01	-	0.78
Total Current Liabilities	69.84	186.28	68.15	115.01	71.71	76.44
Long-Term Debt	242.96	240.43	552.2	738.37	734.14	729.91
Long-Term Leases	17.69	9.24	10.81	9.32	12.69	12.78
Long-Term Deferred Tax Liabilities	0.73	0.39	0.4	0.7	2.01	3.56
Other Long-Term Liabilities	2.08	2.41	2.32	6.32	15.47	93.82
Total Liabilities	333.31	438.75	633.88	869.72	836.03	916.51

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0.01	0.01	0.01	0.01	0.02
Additional Paid-In Capital	585.15	579.96	566.71	541.28	550.32	722.25
Retained Earnings	-527.67	-517.48	-507.97	-478.87	-378.75	-418.71
Comprehensive Income & Other	-1.72	-1.43	-6.95	-3.04	-4.53	-1.26
Shareholders' Equity	55.76	61.06	51.8	59.39	167.05	302.3
Total Liabilities & Equity	389.06	499.8	685.68	929.11	1,003	1,219

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	264.24	378.76	568.16	752.29	753.61	748.56
Net Cash (Debt)	-151.85	-148.08	-200.1	-229.26	-185.41	153.33
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-23.59	-21.81	-28.08	-34.82	-24.97	30.03
Filing Date Shares Outstanding	6.54	6.39	6.26	6.17	6.63	7.53
Total Common Shares Outstanding	6.51	6.38	6.25	6.14	6.61	7.53
Working Capital	131.75	123.24	408.97	583.24	711.56	924.46
Book Value Per Share	8.56	9.58	8.29	9.66	25.27	40.15
Tangible Book Value	-97.98	-101.33	-119.21	-128.55	-3.93	122.59
Tangible Book Value Per Share	-15.04	-15.89	-19.08	-20.92	-0.59	16.28
Machinery	-	14.2	19.46	21.11	17.49	14.31
Construction In Progress	-	0.06	-	0.75	1.38	5.35
Leasehold Improvements	-	11.08	12.02	12.32	11.81	5.09

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error